FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA granted a supplemental approval for Vigabatrin by Actavis Pharma, Inc., updating the product under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)